Department of Genetics and Molecular Biology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Carlos Calvo 856 1° A, CP 1102, Capital Federal, Buenos Aires, Argentina.
Muscle Nerve. 2011 Apr;43(4):510-7. doi: 10.1002/mus.21904. Epub 2011 Feb 8.
Duchenne/Becker muscular dystrophies (DMD/BMD) are X-linked recessive diseases caused by mutations in the dystrophin gene.
We used multiplex polymerase chain reaction (PCR) and short tandem repeat (STR) segregation analysis for DMD/BMD-carrier detection and prenatal diagnosis.
Twenty-four at-risk pregnancies were evaluated: 17 were excluded from carrying dystrophin gene mutations with 95-100% certainty. Of the remaining cases, 2 were determined to carry a dystrophin gene mutation with 95-100% certainty. Three cases had a 67% probability of carrying the mutation, and 2 others were not informative. The certainty of the test increased to ~100% in some cases due to the identification of several genetic events: 4 recombinations; 4 de novo mutations; and 8 deletions encompassing some of the STRs evaluated.
Overall, 19 of 24 (79%) molecular prenatal diagnoses were informative, indicating that multiplex PCR/STR segregation analysis is a reliable method for carrier detection and prenatal diagnosis when other more sophisticated techniques are unavailable.
杜氏/贝克尔肌营养不良症(DMD/BMD)是一种 X 连锁隐性疾病,由 dystrophin 基因突变引起。
我们使用多重聚合酶链反应(PCR)和短串联重复序列(STR)分离分析进行 DMD/BMD 携带者检测和产前诊断。
评估了 24 例高危妊娠:17 例排除携带 dystrophin 基因突变的可能性为 95-100%。其余病例中,2 例确定携带 dystrophin 基因突变的可能性为 95-100%。3 例携带突变的可能性为 67%,另外 2 例则无信息。由于鉴定出了 4 个重组、4 个新生突变和 8 个包含评估的一些 STR 的缺失等几个遗传事件,检测的确定性在某些情况下增加到了~100%。
总体而言,24 例分子产前诊断中有 19 例(79%)具有信息,表明在其他更复杂的技术不可用时,多重 PCR/STR 分离分析是一种可靠的携带者检测和产前诊断方法。